Members of the Mt. Hiram Masonic Lodge No. 595 gathered Saturday for the installment of new officers, which proved to be a rather historic moment. They were joined for the first time by members of Jno G. Lewis Masonic Lodge No. 622, which is also located in Copperas Cove.
âHaving the members of the Jno G. Lewis Masonic Lodge No. 622 here with us at our lodge for the first time is very symbolic, because it put away a lot of myths about us and them being rivals,â said outgoing Worshipful Master Darrell McDonald. âWe were very happy that they could join us this year for this event.â
The voice of victims has been heard.
District Attorney Greg Newman has been removed from office in only the third case of its kind in North Carolina history.
Superior Court Judge Robert C. Ervin issued his order April 27, permanently removing the top criminal prosecutor for Henderson, Polk and Transylvania counties from his elected office, finding Newman engaged in “willful misconduct in office” and “conduct prejudicial to the administration of justice which brings the office into disrepute,” under N.C. General Statute 7A-66.
The decision was made nearly two weeks after a three-day removal hearing April 12-14 in Henderson County Superior Court.
Date Time
Nanobodies inhibit SARS-CoV-2 infection
Australian researchers have identified neutralising nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.
The discovery paves the way for further investigations into nanobody-based treatments for COVID-19.
Visualisation of SARS-CoV-2 virus with nanobodies (purple)
attaching to the virus ‘spike’ protein.
Image: Dr Drew Berry in collaboration with
Associate Professor Wai-Hong Tham
Published in PNAS, the research is part of a consortium-led effort, bringing together the expertise of Australian academic leaders in infectious diseases and antibody therapeutics at WEHI, the Doherty Institute and the Kirby Institute.
At a glance
Researchers have identified nanobodies that effectively blocked the SARS-CoV-2 virus from entering cells in pre-clinical models of COVID-19 infection.